Skip to main content
Pfizer Ltd. logo

Pfizer Ltd. — Investor Relations & Filings

Ticker · PFIZER ISIN · INE182A01018 LEI · 335800XKH6F1JFLUBO78 BSE.NS Manufacturing
Open in API
Filings indexed 1,113 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country IN India
Listing BSE.NS PFIZER

About Pfizer Ltd.

https://www.pfizerltd.co.in/

Pfizer Ltd. is a leading biopharmaceutical company focused on the discovery, development, and manufacture of innovative healthcare products. The company offers a diverse portfolio of medicines and vaccines across several therapeutic areas, including oncology, inflammation and immunology, rare diseases, internal medicine, and anti-infectives. Key products include advanced treatments for cardiovascular health, respiratory conditions, and various infectious diseases. Pfizer Ltd. leverages global research and development capabilities to provide high-quality, science-based solutions aimed at improving patient outcomes and addressing unmet medical needs. The company maintains a significant presence in the market through its commitment to scientific excellence and a robust pipeline of next-generation therapies.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-06-05 English
Please find enclosed Newspaper Advertisement for transfer of unclaimed Dividend and Shares to IEPF.
Regulatory Filings Classification · 72% confidence The document is a letter from Pfizer Ltd. to BSE/NSE enclosing copies of a newspaper advertisement regarding the mandatory transfer of unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF). It is a compliance notice filed with the exchanges, not an actual financial report, dividend declaration, voting notice, or management presentation. This falls under general regulatory announcements to exchanges, making “Regulatory Filings (RNS)” the appropriate category.
2026-06-04 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document is a letter from Pfizer Limited to the BSE and NSE lodging newspaper advertisements for the transfer of unclaimed dividends and shares to the Investor Education and Protection Fund under statutory requirements. It is an announcement to the stock exchanges, not an actual financial report, proxy or dividend amount notice. It does not fit any specific category like dividend declaration, director’s dealings, or AGM materials. It is a general regulatory announcement, so it belongs in the Regulatory Filings (RNS) category.
2026-06-04 English
Special Window for Re-lodgement of Transfer and Dematerialisation of Physical Securities.
Regulatory Filings Classification · 85% confidence The document is a letter to BSE and NSE informing them that Pfizer has published a newspaper advertisement concerning a special window for re-lodgement of transfer and dematerialisation of physical securities and is submitting copies for record. It is not a financial report, dividend notice, capital change, or director dealing; it is a compliance/regulatory announcement to the exchanges. This falls under general regulatory filings (fallback category).
2026-06-03 English
Copy of Newspaper Publication
Regulatory Filings Classification · 82% confidence The document is a brief letter filed with the BSE and NSE to inform them of a newspaper advertisement concerning the re-lodgement of transfer and dematerialisation of physical securities. It does not contain financial results, management changes, dividends, or detailed report content—it is a regulatory compliance notice. This fits the fallback category for miscellaneous regulatory announcements (RNS).
2026-06-03 English
We submit herewith the Annual Secretarial Compliance Report for the financial year ended March 31, 2026, issued by Parikh & Associates, Practicing Company Secretaries.
Regulatory Filings Classification · 95% confidence The document is a submission of the Annual Secretarial Compliance Report pursuant to SEBI LODR Regulation 24A, comprising a Practicing Company Secretary’s certification rather than a financial statement or management discussion. It is an attestation/compliance certificate. Under the classification rules, officer certifications and attestation letters fall under Regulatory Filings (RNS).
2026-05-19 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.